Monoclonal Antibodies (mAbs) Market to Surge as Therapeutic Demand Soars — Industry Readies for Breakthrough Growth The global monoclonal antibodies (mAbs) market is projected to reach a robust value (as estimated in the referenced report), driven by the accelerating demand for targeted therapies, especially in oncology, immunology, and chronic diseases, paired with continuous R&D...